| Application no. and date | 12785416.4 (espacenet) (Federated) (European Patent Register), 20120511 | | Patent/reg. no. and date | DK/EP 2707363, 20151021 | | Publication date | 20140319 | | Priority no. and date | US 201161485691 P, 20110513, US 201161540084 P, 20110928 | | EP pub. no. and date |
EP 2707363 20140319 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | Astra 104161-EP-EPT | | Inventor | MUSIL, Tibor, c/o AstraZeneca Intellectual Property
AstraZeneca R&D Alderley
Alderley Park,
Macclesfield
Cheshire, SK10 4TG, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07B 57/00 (2006.01) , C07D 317/44 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF BENZYL-[(3AS,4R,6S,6AR)-6-HYDROXY-2,2-DIMETHYLTETRAHYDRO-3AH-CYCLOPENTA[D][1,3]-DIOXOL]-4-YL]CARBAMAT OG MELLEMPRODUKTER I FREMGANGSMÅDEN | | Int. application no. | SE2012050498 | | Int. publication no. | WO2012158099 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
